SDJVC
CLGN icon

St. Denis J. Villere & Co’s CollPlant Biotechnologies CLGN Stock Holding History

St. Denis J. Villere & Co’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Sell
60,640
-90
-0.1% -$347 0.03% 81
2026
Q1 		$326K Hold
60,730
– – 0.04% 59
2025
Q4 		$850K Buy
60,730
+1,858
+3% +$38K 0.09% 44
2025
Q3 		$1.58M Buy
58,872
+4,185
+8% +$99.8K 0.15% 40
2025
Q2 		$744K Buy
54,687
+6,300
+13% +$130K 0.07% 44
2025
Q1 		$1.25M Hold
48,387
– – 0.12% 42
2024
Q4 		$1.74M Sell
48,387
-100
-0.2% -$4.07K 0.16% 43
2024
Q3 		$2.41M Buy
48,487
+9,500
+24% +$465K 0.2% 43
2024
Q2 		$1.94M Buy
38,987
+2,290
+6% +$127K 0.16% 44
2024
Q1 		$1.96M Buy
36,697
+568
+2% +$30.7K 0.16% 42
2023
Q4 		$2.31M Buy
36,129
+6,112
+20% +$334K 0.19% 42
2023
Q3 		$1.67M Buy
30,017
+745
+3% +$49.3K 0.14% 44
2023
Q2 		$2.39M Buy
29,272
+292
+1% +$21.3K 0.17% 44
2023
Q1 		$2.03M Buy
28,980
+265
+0.9% +$26K 0.15% 45
2022
Q4 		$2.4M Buy
28,715
+95
+0.3% +$6.5K 0.19% 47
2022
Q3 		$1.95M Buy
28,620
+1,930
+7% +$157K 0.15% 45
2022
Q2 		$2.13M Buy
26,690
+90
+0.3% +$8.27K 0.16% 43
2022
Q1 		$2.98M Buy
26,600
+913
+4% +$100K 0.18% 42
2021
Q4 		$4.2M Buy
25,687
+872
+4% +$156K 0.24% 41
2021
Q3 		$4.19M Buy
24,815
+90
+0.4% +$16.2K 0.24% 43
2021
Q2 		$5.24M Buy
24,725
+500
+2% +$79.9K 0.28% 40
2021
Q1 		$3.25M Buy
24,225
+15,440
+176% +$2.33M 0.18% 41
2020
Q4 		$946K Buy
8,785
+4,505
+105% +$364K 0.06% 41
2020
Q3 		$356K Buy
4,280
+2,500
+140% +$225K 0.02% 50
2020
Q2 		$177K Buy
+1,780
New +$183K 0.01% 52

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $243M AUM 8.27% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

St. Denis J. Villere & Co's CLGN Position: Q2 2026 in Review

St. Denis J. Villere & Co reduced its CollPlant Biotechnologies (CLGN) stake by 0.15% in Q2 2026, selling an estimated $347 and leaving 60,640 shares worth $212K. The position accounts for 0.03% of the portfolio, ranked #81.

St. Denis J. Villere & Co first reported a position in CLGN in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.24M in Q2 2021. 15 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • St. Denis J. Villere & Co held 60,640 shares of CollPlant Biotechnologies worth $212K as of Q2 2026.
  • St. Denis J. Villere & Co sold 90 CollPlant Biotechnologies shares in Q2 2026, an estimated $347.
  • CollPlant Biotechnologies made up 0.03% of St. Denis J. Villere & Co's portfolio in Q2 2026, its #81 holding.
  • St. Denis J. Villere & Co first reported a position in CollPlant Biotechnologies in Q2 2020 and has held it in 25 quarters since.
  • St. Denis J. Villere & Co's CollPlant Biotechnologies position peaked at $5.24M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on St. Denis J. Villere & Co's 13F filing for Q2 2026, filed 7 Aug 2026.